Because of these limitations,
most pancreatic cancer research relies on genetically engineered mouse models of the disease, which can take up to one year to generate.
«This
research represents a big step forward in understanding why some tumors are more aggressive than others and being able to predict rationally which neoantigens will be the most effective at stimulating an immune response,» said Dr. Balachandran, a member of the David M. Rubenstein Center for Pancreatic Cancer Research at MSK, and corresponding author of the companion study in
research represents a big step forward in understanding why some tumors are more aggressive than others and being able to predict rationally which neoantigens will be the
most effective at stimulating an immune response,» said Dr. Balachandran, a member of the David M. Rubenstein Center for
Pancreatic Cancer Research at MSK, and corresponding author of the companion study in
Research at MSK, and corresponding author of the companion study in Nature.
Tal Danino, a professor at the Data Science Institute, is conducting
research that could help scientists combat the
most lethal of
cancers:
pancreatic cancer.